|
Sino Biological
cdk1 cyclin a2 Cdk1 Cyclin A2, supplied by Sino Biological, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+cdk1/Anti-CDK1/pmc05346690-161-55-60 Average 90 stars, based on 1 article reviews
cdk1 cyclin a2 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Atlas Antibodies
cdk1 ![]() Cdk1, supplied by Atlas Antibodies, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+cdk1/Anti-CDK1/bio_rxiv__041723-134-57-60 Average 88 stars, based on 1 article reviews
cdk1 - by Bioz Stars,
2026-11
88/100 stars
|
Buy from Supplier |
|
Boster Bio
anti cdk1 ![]() Anti Cdk1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+cdk1/Anti-CDK1+Antibody/pmc13656039-162-27-30 Average 94 stars, based on 1 article reviews
anti cdk1 - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Cusabio
p cdk1 t161 ![]() P Cdk1 T161, supplied by Cusabio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+cdk1/Rabbit+anti-+Phospho-CDK1+Polyclonal+Antibody/pmc10728000-79-23-26 Average 91 stars, based on 1 article reviews
p cdk1 t161 - by Bioz Stars,
2026-11
91/100 stars
|
Buy from Supplier |
|
Thermo Fisher
gene exp cdk1 mm00772471 m1 ![]() Gene Exp Cdk1 Mm00772471 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+cdk1/Anti+Gene+Exp%2E+cdk1+mm00772471+m1/pmc04107318__NIHMS585589___supplement___1-94-57--1 Average 85 stars, based on 1 article reviews
gene exp cdk1 mm00772471 m1 - by Bioz Stars,
2026-11
85/100 stars
|
Buy from Supplier |
|
Boster Bio
p cdc2 ![]() P Cdc2, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+cdk1/Anti-PSTAIR+Antibody/pmc05958718-111-14-27 Average 90 stars, based on 1 article reviews
p cdc2 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Boster Bio
rabbit anti casp3 antibody ![]() Rabbit Anti Casp3 Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+cdk1/Anti-Phospho-cdc2+(Tyr15)+CDK1+Antibody/pmc10494837-85-10-36 Average 92 stars, based on 1 article reviews
rabbit anti casp3 antibody - by Bioz Stars,
2026-11
92/100 stars
|
Buy from Supplier |
|
Boster Bio
rabbit anti cdk1 antibody pb9533 ![]() Rabbit Anti Cdk1 Antibody Pb9533, supplied by Boster Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+cdk1/Anti-CDK1+Antibody+Picoband/pmc10494837-85-14-36 Average 92 stars, based on 1 article reviews
rabbit anti cdk1 antibody pb9533 - by Bioz Stars,
2026-11
92/100 stars
|
Buy from Supplier |
|
Sino Biological
cdk1 ![]() Cdk1, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+cdk1/Anti-CDC2+Kinase+%2F+CDK1+Magnetic+Beads+Immunoprecipitation+(IP)+Kit/pm39901205-79-3-5 Average 94 stars, based on 1 article reviews
cdk1 - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Affinity Biosciences
anti-cdk1 ![]() Anti Cdk1, supplied by Affinity Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+cdk1/anti+cdk1/pm39736624-42-0-18 Average 90 stars, based on 1 article reviews
anti-cdk1 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Becton Dickinson
cdk1/cdc2 (clone 1; 1: 2,500) ![]() Cdk1/Cdc2 (Clone 1; 1: 2,500), supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+cdk1/anti+cdk1/pmc02505183-183-37-44 Average 90 stars, based on 1 article reviews
cdk1/cdc2 (clone 1; 1: 2,500) - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
AnaSpec
rabbit polyclonal anti-cdk-1 antisera ![]() Rabbit Polyclonal Anti Cdk 1 Antisera, supplied by AnaSpec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+cdk1/anti+cdk1++ptyr15++antibody/pmc03329775-88-60-65 Average 90 stars, based on 1 article reviews
rabbit polyclonal anti-cdk-1 antisera - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: bioRxiv
Article Title: Cdk activity drives senescence from G2 phase
doi: 10.1101/041723
Figure Lengend Snippet: ( A ) Mean and standard deviation from 4 independent experiments of RPE cells treated with Etoposide and after 1h with Roscovitine, MK-1775 (MK) or with DMSO. Alternatively cells were transfected with RNAi for Cdk1 and Cdk2 at 24 and 48h before damage induction in 3 independent experiments. Cells were stained for β-Galactosidase 4 days later. Statistical hypothesis testing was performed using two-sided t -test. (B) Quantification of nuclear H3K9Me2, HP1b, and IL-6 levels in RPE cells treated with Etoposide and after 1h with Roscovitine, MK-1775 (MK) or with DMSO. Alternatively cells were transfected with RNAi for Cdk1 and Cdk2 at 24 and 48h before damage induction. Cells were fixed 5 days after damage induction. Statistical hypothesis testing was performed using two-sided t -test. (C) Analysis of proliferative capacity. RPE cells were treated with Etoposide and 1h later with Roscovitine, MK-1775 or DMSO. Cells were counted after 5 days, reseeded into fresh medium and counted again after 2 more days. Mean and standard deviation of 3 independent experiments ran in quadruplicates are shown. Statistical hypothesis testing was performed using two-sided t -test. (D) Analysis of clonogenic capacity. RPE cells were treated with Etoposide and 1h later with Roscovitine, MK-1775 or DMSO. After 5 days 5000 cells were reseeded into fresh medium and the number of colonies was assessed one week later. Normalized mean and standard deviation of 3 independent experiments ran in quadruplicates are shown. Statistical hypothesis testing was performed using two-sided t -test.
Article Snippet: The following antibodies were used: Lamin A/C pS22 (1:400; #2026 Cell Signaling), Cdc6 pS54 EPR759Y (1:200; ab75809 abcam), Cyclin B1 pS126 (1:200; ab55184 abcam, 1:100; ab3488 abcam), p53 DO-1 (1:500; sc-126 Santa Cruz), p53 pSer15 (1:200, #9284 Cell Signaling), p21 12D1 (1:1000; #2947 Cell Signaling), β-tubulin 9F3 (1:1000; #2128S Cell Signaling), Cdk1 POH1 (1:1000; #9116 Cell Signaling),
Techniques: Standard Deviation, Transfection, Staining
Journal: bioRxiv
Article Title: Cdk activity drives senescence from G2 phase
doi: 10.1101/041723
Figure Lengend Snippet: (A) Western blot of a typical siRNA knockdown of Cdk1 and Cdk2 in a 96-well format. Cells were transfected with RNAi for Cdk1 and Cdk2 24 and 48h before sample preparation. (B) Increased nuclear size as an indicator of cellular senescence . RPE cells were treated with Etoposide. Roscovitine or DMSO were added 1h later. Alternatively, cells were transfected with siRNA for Cdk1 and Cdk2 at 24 and 48h before damage induction. Cells were fixed 4 days after damage induction, stained with DAPI and nuclear size was assessed in more than 250 cells for each condition. Statistical hypothesis testing was performed using two-sided t -test. (C) Quantification of nuclear H3K9Me2, HP1b, and IL-6 levels in control RPE cells and cells treated with Etoposide for 5 days. Statistical hypothesis testing was performed using two-sided t -test. (D) Quantification of nuclear foci intensity of H3K9Me2 and HP1b, and cytoplasmic IL-6 levels. RPE cells treated with Etoposide and after 1h with Roscovitine, MK-1775 (MK) or with DMSO. Alternatively cells were transfected with siRNA for Cdk1 and Cdk2 at 24 and 48h before damage induction in 3 independent experiments. Cells were fixed 5 days after damage induction. Statistical hypothesis testing was performed using two-sided t -test. ( E )Colony formation capacity of RPE cells treated with Etoposide and DMSO,Roscovitine (Rosc) or MK-1775. Data from 3 independent experiments are shown.
Article Snippet: The following antibodies were used: Lamin A/C pS22 (1:400; #2026 Cell Signaling), Cdc6 pS54 EPR759Y (1:200; ab75809 abcam), Cyclin B1 pS126 (1:200; ab55184 abcam, 1:100; ab3488 abcam), p53 DO-1 (1:500; sc-126 Santa Cruz), p53 pSer15 (1:200, #9284 Cell Signaling), p21 12D1 (1:1000; #2947 Cell Signaling), β-tubulin 9F3 (1:1000; #2128S Cell Signaling), Cdk1 POH1 (1:1000; #9116 Cell Signaling),
Techniques: Western Blot, Knockdown, Transfection, Sample Prep, Staining, Control
Journal: bioRxiv
Article Title: Cdk activity drives senescence from G2 phase
doi: 10.1101/041723
Figure Lengend Snippet: ( A ) Asynchronous growing RPE Cyclin A2-eYFP cells were treated with Etoposide or NCS for 4h, lysed and immunoprecipitated with anti-GFP or control antibody. Kinase assay was performed using GST-Cdk substrate peptide and phosphorylation was detected by autoradiography. Co-immunoprecipitation of Cdk2 and Cdk1 was determined by immunoblotting. Arrowhead shows position of Cdk1, empty arrowhead indicates position of IgG. WCL, whole cell lysate. (B) RPE Cyclin B1-eYFP cells were released for 6h from a thymidine block, treated with Etoposide or NCS for 4h, lysed and immunoprecipitated with anti-GFP or control antibody. Kinase assay was performed using GST-LAMS22 substrate peptide and phosphorylation was detected by antibody against Lamin A/C phosphorylated at Ser22. WCL, whole cell lysate. (C) RPE cells were released for 6h from a thymidine block, treated with Etoposide for 4h, lysed and immunoprecipitated with anti-Cdk2 or control antibody. Kinase assay was performed in the absence or presence of Roscovitine and kinase activity was determined as in (a).
Article Snippet: The following antibodies were used: Lamin A/C pS22 (1:400; #2026 Cell Signaling), Cdc6 pS54 EPR759Y (1:200; ab75809 abcam), Cyclin B1 pS126 (1:200; ab55184 abcam, 1:100; ab3488 abcam), p53 DO-1 (1:500; sc-126 Santa Cruz), p53 pSer15 (1:200, #9284 Cell Signaling), p21 12D1 (1:1000; #2947 Cell Signaling), β-tubulin 9F3 (1:1000; #2128S Cell Signaling), Cdk1 POH1 (1:1000; #9116 Cell Signaling),
Techniques: Immunoprecipitation, Control, Kinase Assay, Phospho-proteomics, Autoradiography, Western Blot, Blocking Assay, Activity Assay
Journal: bioRxiv
Article Title: Cdk activity drives senescence from G2 phase
doi: 10.1101/041723
Figure Lengend Snippet: (A) Representative Western blot of RPE cells treated with Etoposide and with a combination of Roscovitine, RO-3306 and NU6140 (Cdk inh.) or mock treatment with DMSO 1h later. Cell lysates were prepared at the indicated time points. C, control. (B) Representative Western blots of RPE cells treated with Etoposide and with Roscovitine (Cdk1/2), MK1775 (Wee1), SB202190 (p38) or mock treatment with DMSO 1h later (left blot). Alternatively cells were transfected with the indicated siRNA at 24 and 48h before damage induction (right blot). C, Control. (C) Representative Western blots of RPE cells transfected with Cdk1AF-GFP or control, with and without 4h Etoposide treatment. (D) Quantification of nuclear p21 levels and nuclear p53 level versus estimated time. Cells were sorted for DAPI and Cyclin B1. Cells were treated with Etoposide at 1 µM concentration or mock treated with DMSO (control). Roscovitine, a combination of RO-3306 and NU6140, or DMSO was added 1h after Etoposide treatment. Cells were fixed after 4h. More than 350 cells were analyzed for each condition. ( E )Immunofluorescence quantification of nuclear p21 levels in G2 cells. RPE cellswere treated with Etoposide and 1h later with Roscovitine (Cdk inhibition) incombination with the indicated drug (DMSO, CHX, MG, nutlin). Cells were fixed 4hafter damage and G2 cells were identified according to DNA content using DAPIstaining. ( F )Representative Western blot of RPE cells treated with Etoposide at time point 0and 1h later with Cycloheximide alone, or Cycloheximide in combination with Cdkinhibition (Roscovitine, RO-3306 and NU6140 - Cdk inh.). Cell lysates wereprepared at the indicated time points. Below, quantification of p21 and p53degradation kinetics. The average and standard deviation of three independentexperiments are shown. ( G )RPE cells were treated with Etoposide and 1h later with Roscovitine, acombination of RO-3306 and NU6140, or mock treatment with DMSO. Means andstandard deviation of RT-qPCR measurements obtained in 4 independent experimentsare shown. Statistical hypothesis testing was performed using two-sided t -test. (H) Cdk activity determines cell fate decisions towards mitosis in unperturbed conditions or towards senescence upon DNA damage.
Article Snippet: The following antibodies were used: Lamin A/C pS22 (1:400; #2026 Cell Signaling), Cdc6 pS54 EPR759Y (1:200; ab75809 abcam), Cyclin B1 pS126 (1:200; ab55184 abcam, 1:100; ab3488 abcam), p53 DO-1 (1:500; sc-126 Santa Cruz), p53 pSer15 (1:200, #9284 Cell Signaling), p21 12D1 (1:1000; #2947 Cell Signaling), β-tubulin 9F3 (1:1000; #2128S Cell Signaling), Cdk1 POH1 (1:1000; #9116 Cell Signaling),
Techniques: Western Blot, Control, Transfection, Concentration Assay, Immunofluorescence, Inhibition, Standard Deviation, Quantitative RT-PCR, Activity Assay
Journal: PeerJ
Article Title: Dieting alleviates hyperuricemia and organ injuries in uricase-deficient rats via down-regulating cell cycle pathway
doi: 10.7717/peerj.15999
Figure Lengend Snippet: (A) Casp3, Cdk1 and Ki67 in the liver was evaluated at mRNA level, and a high value of FPKM means a high expression; (B) Casp3, Cdk1 and Ki67 in the liver was evaluated by Western blot; C, Results of B were quantified by relative brightness. FPKM, Fragments Per Kilobase of exon model per Million mapped fragments. Control, control group, KDY rats were given free approach to food and water; 75% dieting, 75% dieting group, rats were given 75% food of control group at the same age in days and given free access to water. * P < 0.05 vs control group, Student’s t -test, two-tailed.
Article Snippet: Hematoxylin-eosin (HE) staining kits, mouse anti- β -actin antibody (BM0627),
Techniques: Expressing, Western Blot, Control, Two Tailed Test
Journal: PeerJ
Article Title: Dieting alleviates hyperuricemia and organ injuries in uricase-deficient rats via down-regulating cell cycle pathway
doi: 10.7717/peerj.15999
Figure Lengend Snippet: (A) Casp3, Cdk1 and Ki67 in the liver was evaluated at mRNA level, and a high value of FPKM means a high expression; (B) Casp3, Cdk1 and Ki67 in the liver was evaluated by Western blot; C, Results of B were quantified by relative brightness. FPKM, Fragments Per Kilobase of exon model per Million mapped fragments. Control, control group, KDY rats were given free approach to food and water; 75% dieting, 75% dieting group, rats were given 75% food of control group at the same age in days and given free access to water. * P < 0.05 vs control group, Student’s t -test, two-tailed.
Article Snippet: Hematoxylin-eosin (HE) staining kits, mouse anti- β -actin antibody (BM0627), rabbit anti-CASP3 antibody (BA2142),
Techniques: Expressing, Western Blot, Control, Two Tailed Test